Boston, MA -- (SBWIRE) -- 10/25/2016 -- This market report summarizes the results of an industry-wide global web-based benchmarking survey on outsourced ion channel testing carried out in July 2016.

The survey was initiated by the publisher as part of its tracking of life science marketplaces and to update the previous outsourced ion channel testing trends report (published May 2013).

The questionnaire was compiled to meet the needs and interests of the outsourced ion channel testing provider community.

The main objectives were to comprehensively document current use of and potential interest in outsourcing ion channel primary screening, selectivity profiling and safety liability testing. The survey also investigated access to stably transfected cell lines and future purchasing plans. The aim was to compile a reference document on outsourced ion channel testing, which could be compared directly relative to the previous 2013 report. Equal emphasis was given to soliciting opinion from Pharma, Biotech and Academic Research market segments globally.

To view a detailed description and Table of Contents please visit: http://bit.ly/2dF1fEJ

The survey questionnaire consisted of 32 mainly multi-choice questions. In addition, there were 6 questions related solely to survey demographics.

The survey collected 71 validated responses, of these 75% provided comprehensive input.

Survey responses were geographically split: 38% North America; 35% Europe; 11% Asia (excluding Japan and China); 10% Japan; 3% China and 3% Rest of World.

Survey respondents were drawn from persons or groups actively using or interested in using outsourced ion channel primary screening, selectivity profiling and safety liability testing.

Respondents came from 23 Large Pharma; 15 Biotech Company; 14 Medium-Small Pharma; 9 University; 3 Research Institute: 2 Government Lab; 2 Academic Screening Center; 2 Other; and 1 Hospital/Clinic/ Medical School.

Most survey respondents had a senior job role or position which was in descending order: 11 research scientists; 11 section/group leaders; 11 senior scientists/researchers; 8 directors; 7 principal investigators; 6 lab managers; 6 professors/assistant professors; 4 department heads; 4 others; 2 outsourcing managers; and 1 vice president.

Survey results were expressed as an average of all survey respondents. In addition, where appropriate the data was reanalyzed after sub-division into the following 5 survey groups: 1) Large Pharma; 2) Other Screening Labs; 3) Academic Research; 4) Europe; and 5) North America.

The full report provides the data, details of the breakdown of the responses for each question, its segmentation, CAGR and the estimates for the future (2018). It also highlights some interesting differences between the survey groups.

To enquire about this Report please visit @ http://bit.ly/2eMUSLr

About ReportsWorldwide.com
ReportsWorldwide.com is a leading provider of global market intelligence reports and services. With research reports from top publishers, consulting and advisory firms, ReportsWorldwide.com offers instant online access to a growing database of expert insights on global industries, companies, products, geographies and trends.